Measurement of MHC/peptide interactions by gel filtration or monoclonal antibody capture

Current Protocols in Immunology

Volumn , Issue SUPPL.100, 2013, Pages

  Sidney, John ^a   Southwood, Scott ^a   Moore, Carrie ^a   Oseroff, Carla ^a   Pinilla, Clemencia ^a   Grey, Howard M ^a   Sette, Alessandro ^a  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

BCTL; Binding affinity; Epitope recognition; MHC class I; MHC class II; Peptide ligand; T cell epitope

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MONOCLONAL ANTIBODY; ANTIGEN; HISTOCOMPATIBILITY ANTIGEN; PEPTIDE FRAGMENT;

AFFINITY CHROMATOGRAPHY; ANTIBODY AFFINITY; ANTIGEN PURIFICATION; ARTICLE; BINDING AFFINITY; BINDING ASSAY; CONTROLLED STUDY; GEL FILTRATION CHROMATOGRAPHY; INCUBATION TIME; ISOTOPE LABELING; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN INTERACTION; SENSITIVITY ANALYSIS; ANIMAL; GEL CHROMATOGRAPHY; HUMAN; IMMUNOLOGY; METABOLISM; RADIOASSAY;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS; CHROMATOGRAPHY, GEL; HISTOCOMPATIBILITY ANTIGENS; HUMANS; PEPTIDE FRAGMENTS; PROTEIN BINDING; RADIOLIGAND ASSAY;

MLCS; MLOWN;

EID: 84880471966     PISSN: 19343671     EISSN: 1934368X     Source Type: Journal    
DOI: 10.1002/0471142735.im1803s100     Document Type: Article

References (120)

1. Alexander, J., Sidney, J., Southwood, S., Ruppert, J., Oseroff, C., Maewal, A., Snoke, K., Serra, H.M., Kubo, R.T., Sette, A., and Grey, H.M. 1994. Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides. Immunity 1:751-761.
2. Allen, T.M., Sidney, J., del Guercio, M.F., Glickman, R.L., Lensmeyer, G.L., Wiebe, D.A., De- Mars, R., Pauza, C.D., Johnson, R.P., Sette, A., andWatkins, D. I. 1998. Characterization of the peptide binding motif of a rhesus MHC class I molecule (Mamu-A*01) that binds an immunodominant CTL epitope from simian immunodeficiency virus. J. Immunol. 160:6062-6071.
3. Arlehamn, C.S., Sidney, J., Henderson, R., Greenbaum, J.A., James, E.A., Moutaftsi, M., Coler, R., McKinney, D.M., Park, D., Taplitz, R., Kwok,W.W., Grey, H., Peters, B., and Sette, A. 2012. Dissecting mechanisms of immunodominance to the common tuberculosis antigens ESAT-6, CFP10, Rv2031c (hspX), Rv2654c (TB7.7), and Rv1038c (EsxJ). J. Immunol. In press.
4. Assarsson, E., Sidney, J., Oseroff, C., Pasquetto, V., Bui, H.-H., Frahm, N., Brander, C., Peters, B., Grey, H. and Sette, A. 2007. A quantitative analysis of the variables affecting the repertoire of T cell specificities recognized after vaccinia virus infection. J. Immunol. 178:7890-7901.
5. Assarsson, E., Bui, H.-H., Sidney, J., Zhang, Q., Glenn, J., Oseroff, C., Mbawuike, I.N., Alexander, J., Newman, M.J., Grey, H., and Sette, A. 2008. Immunomic analysis of the repertoire of T-cell specificities for influenza A virus in humans. J. Virol. 82:12241-12251.
6. Barber, L.D. and Parham, P. 1993. Peptide binding to major histocompatibility complex molecules. Annu. Rev. Cell Biol. 9:163-206.
7. Bolton, A.E. and Hunter, W.M. 1986. Radioimmunoassay and related methods. In Handbook of Experimental Immunology, Vol. 1: Immunochemistry (D.M. Weir, L.A. Herzenberg, C. Blackwell, and L.A. Herzenberg, eds.) pp. 26.1-26.56. Blackwell Scientific, Oxford.
8. Bonifacino, A., Dasso, M., Harford, J.B., Lippincott-Schwartz, J., and Yamada, K.M. 2013. Current Protocols in Cell Biology. John Wiley & Sons, Hoboken, N.J.
9. Boyd, L.F., Kozlowski, S., and Margulies, D.H. 1992. Solution binding of an antigenic peptide to a major histocompatibility complex class I molecule and the role of β2-microglobulin. Proc. Natl. Acad. Sci. U.S.A. 89:2242-2246.
10. Buchli, R.,VanGundy, R.S., Hickman-Miller, H.D., Giberson, C.F., Bardet, W., and Hildebrand, W.H. 2004. Real-time measurement of in vitro peptide binding to soluble HLA-A*0201 by fluorescence polarization. Biochemistry 43:14852- 14863.
11. Buchli, R., VanGundy, R.S., Hickman-Miller, H.D., Giberson, C.F., Bardet, W., and Hildebrand, W.H. 2005. Development and validation of a fluorescence polarization-based competitive peptide-binding assay for HLA-A*0201-a new tool for epitope discovery. Biochemistry 44:12491-12507.
12. Bui, H.H., Sidney, J., Peters, B., Sathiamurthy, M., Sinichi, A., Purton, K.A., Mothe, B.R., Chisari, F.V., Watkins, D.I., and Sette, A. 2005. Automated generation and evaluation of specific MHC binding predictive tools: ARB matrix applications. Immunogenetics 57:304-314.
13. Busch, R., Strang, G., Howland, K., and Rothbard, J.B. 1990. Degenerate binding of immunogenic peptides to HLA-DR proteins on B cell surfaces. Int. Immunol. 2:443-451.
14. Buus, S., Sette, A., Colon, S.M., Jenis, D.M., and Grey, H.M. 1986. Isolation and characterization of antigen-Ia complexes involved inTcell recognition. Cell 47:1071-1077.
15. Buus, S., Sette, A., Colon, S.M., Miles, C., and Grey, H.M. 1987. The relation between major histocompatibility complex (MHC) restriction and the capacity of Ia to bind immunogenic peptides. Science 235:1353-1358.
16. Buus, S., Sette, A., Colon, S.M., and Grey, H.M. 1988. Autologous peptides constitutively occupy the antigen binding site on Ia. Science 242:1045-1047.
17. Buus, S., Stryhn, A., Winther, K., Kirkby, N., and Pedersen, L.O. 1995. Receptor-ligand interactions measured by an improved spun column chromatography technique. A high efficiency and high throughput size separation method. Biochim. Biophys. Acta 1243:453-460.
18. Ceppellini, R., Frumento, G., Ferrara, G.B., Tosi, R., Chersi, A., and Pernis, B. 1989. Binding of labelled influenza matrix peptide to HLA DR in living B lymphoid cells. Nature 339:392-394.
19. Cerundolo, V., Elliott, T., Elvin, J., Bastin, J., Rammensee, H.-G., and Townsend, A. 1991. The binding affinity and dissociation rates of peptides for class I major histocompatibility complex molecules. J. Immunol. 21:2069-2075.
20. Cheng, Y. and Prusoff, W.H. 1973. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem. Pharmacol. 22:3099-3108.
21. Christnick, E.R., Luscher, M.A., Barber, B.H., and Williams, D.B. 1991. Peptide binding to class I MHC on living cells and quantitation of complexes required for CTL lysis. Nature 352:67- 70.
22. Cox, A.L., Skipper, J., Chen, Y., Henderson, R.A., Darrow, T.L., Shabanowitz, J., Engelhard, V.H., Hunt, D.F., and Slingluff, C.L. Jr. 1994. Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines. Science 264:716-719.
23. Dedier, S., Reinelt, S., Rion, S., Folkers, G., and Rognan, D. 2001. Use of fluorescence polarization to monitor MHC-peptide interactions in solution. J. Immunol. Methods 255:57-66.
24. del Guercio, M.-F., Sidney, J., Hermanson, G., Perez, C., Grey, H.M., Kubo, R.T., and Sette, A. 1995. Binding of a peptide antigen to multiple HLA alleles allows definition of an A2-like supertype. J. Immunol. 154:685-693.
25. Engelhard, V.H. 1994. Structure of peptides associated with class I and class II MHC molecules. Annu. Rev. Immunol. 12:181-207.
26. Falk, K., R̈otzschke, O., Stevanovic, S., Jung, G., andRammensee, H.G. 1991. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 351:290- 296.
27. Ferre,H., Ruffet, E., Blicher, T., Sylvester-Hvid, C., Nielsen, L.L., Hobley, T.J., Thomas, O.R., and Buus, S. 2003. Purification of correctly oxidized MHC class I heavy-chain molecules under denaturing conditions: A novel strategy exploiting disulfide assisted protein folding. Protein Science. 12:551-559.
28. Geluk, A., van Meijgaarden, K.E., Southwood, S., Oseroff, C., Wouter Drijfhout, J., de Vries, R.R.P., Ottenhoff, T.H.M., and Sette, A. 1994. HLA-DR3 molecules can bind peptides carrying two alternative specific submotifs. J. Immunol. 152:5742-5748.
29. Germain, R.N. 1993. Antigen processing and presentation. In Fundamental Immunology, 3rd ed. (W.E. Paul, ed.) pp. 629-676. Raven Press, New York.
30. Germain, R.N. 1994. MHC-dependent antigen processing and peptide presentation: Providing ligands for T lymphocyte activation. Cell 76:287- 299.
31. Germain, R.N. and Margulies, D.H. 1993. The biochemistry and cell biology of antigen processing and presentation. Annu. Rev. Immunol. 11:403- 450.
32. Greenbaum, J., Sidney, J., Chung, J., Brander, C., Peters, B., and Sette, A. 2011. Functional classification of class II human leukocyte antigen (HLA) molecules reveals seven different supertypes and a surprising degree of repertoire sharing across supertypes. Immunogenetics 63:325-335.
33. Greenwood, F., Hunter, W., and Glover, J. 1963. The preparation of 131I-labeled human growth hormone of high specific radioactivity. Biochem. J. 89:114-123.
34. Gulukota, K., Sidney, J., Sette, A., and DeLisi, C. 1997. Two complementary methods for predicting peptides binding major histocompatibility complex molecules. J. Mol. Biol. 267:1258- 1267.
35. Hammer, J. 1995. New methods to predict MHCbinding sequences within protein antigens. Curr. Opin. Immunol. 7:263-269.
36. Hammer, J., Valsasnini, P., Tolba, K., Bolin, D., Higelin, J., Takacs, B., and Sinigaglia, F. 1993. Promiscuous and allele-specific anchors in HLA-DR-binding peptides. Cell 74:197-203.
37. Hammer, J., Bono, E., Gallazzi, F., Belunis, C., Nagy, Z., and Sinigaglia, F. 1994. Precise prediction of major histocompatibility complex class II-peptide interaction based on peptide side chain scanning. J. Exp. Med. 180:2353-2358.
38. Harndahl,M., Justesen, S., Lamberth, K.,Roder, G., Nielsen, M., and Buus, S. 2009. Peptide binding to HLA class I molecules: Homogenous, high-throughput screening, and affinity assays. J. Biomol. Screen. 14:173-180.
39. Harndahl,M., Rasmussen, M.,Roder, G., and Buus, S. 2011. Real-time, high-throughput measurements of peptide-MHC-I dissociation using a scintillation proximity assay. J. Immunol. Methods 374:5-12.
40. Harris, P.E., Colovai, A., Liu, Z., Dalla Favera, R., and Suciu-Foca, N. 1993. Naturally processed HLA class I bound peptides from c-myctransfected cells reveal allele-specific motifs. J. Immunol. 151:5966-5974.
41. Hill, C.M., Hayball, J.D., Allison, A.A., and Rothbard, J.B. 1991. Conformational and structural characteristics of peptide binding to HLA-DR molecules. J. Immunol. 147:189-197.
42. Hill, C.M., Liu, A., Marshall, K.W., Mayer, J., Jorgensen, B., Yuan, B., Cubbon, R.M., Nichols, E.A., Wicker, L.S., and Rothbard, J.B. 1994. Exploration of requirements for peptide binding to HLA DRB1*0101 and DRB1*0401. J. Immunol. 152:2890-2898.
43. Hoof, I., Peters, B., Sidney, J., Pedersen, L.E., Sette, A., Lund, O., Buus, S., and Nielsen, M. 2009. NetMHCpan, a method for MHC class I binding prediction beyond humans. Immunogenetics 61:1-13.
44. Hunt, D.F., Henderson, R.A., Shabanowitz, J., Sakaguchi, K., Michel, H., Sevilir, N., Cox, A.L., Appella, E., and Engelhard, V.H. 1992. Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry. Science 255:1261-1266.
45. Janeway, C.A., Conrad, P.J., Lerner, E.A., Babich, J., Wettstein, P., and Murphy, D.B. 1984. Monoclonal antibodies specific for Ia glycoproteins raised by immunization with activated T cells: Possible role of T cell bound Ia antigens as targets of immunoregulatory T cells. J. Immunol. 132:662-667.
46. Joyce, S. and Nathenson, S.G. 1994. Methods to study peptides associated with MHC class I molecules. Curr. Opin. Immunol. 6:24-31.
47. Justesen, S., Harndahl, M., Lamberth, K., Nielsen, L.L., and Buus, S. 2009. Functional recombinant MHC class II molecules and high-throughput peptide-binding assays. Immunome Res. 5:2.
48. Khilko, S.N., Corr, M., Boyd, L.F., Lees,A., Inman, J.K., and Margulies, D.H. 1993. Direct detection of major histocompatibility complex class I binding to antigenic peptides using surface plasmon resonance. J. Biol. Chem. 268:15425- 15434.
49. Kondo, A., Sidney, J., Southwood, S., del Guercio, M.-F., Appella, E., Sakamoto, J., Celis, E., Grey, H.M., Chesnut, R.W., Kubo, R.T., and Sette, A. 1995. Prominent roles of secondary anchor residues in peptide binding to HLA-A24 human class I molecules. J. Immunol. 155:4307-4312.
50. Kondo, A., Sidney, J., Southwood, S., del Guercio, M.-F., Appella, E., Sakamoto, J., Celis, E., Grey, H.M., Celis, E., Chesnut, R.W., Kubo, R.T., and Sette, A. 1997. Two distinct HLA-A*0101- specific submotifs illustrate alternative peptide binding modes. Immunogenetics 45:249-258.
51. Kotturi, M., Peters, B., Buendia-Laysa, F., Sidney, J., Oseroff, C., Botten, J., Grey, H., Buchmeier, M., and Sette, A. 2007. The CD8+ T-cell response to lymphocytic choriomeningitis virus involves the L antigen: Uncovering new tricks for an old virus. J. Virol. 81:4928-4940.
52. Kotturi, M.F., Botten, J., Sidney, J., Bui, H.-H., Giancola, L., Maybeno, M., Babin, J., Oseroff, C., Pasquetto, V., Greenbaum, J.A., Peters, B., Ting, J., Do, D., Vang, L., Alexander, J., Grey, H., Buchmeier, M.J., and Sette, A. 2009. A multivalent and cross-protective vaccine strategy against Arenaviruses associated with human disease. PLoS Pathog. 5:e1000695.
53. Kotturi, M., Botten, J., Maybeno, M., Sidney, J., Glenn, J., Bui, H.-H., Oseroff, C., Crotty, S., Peters, B., Grey, H., Altmann, D., Buchmeier, M., and Sette, A. 2010. Polyfunctional CD4+ T cell responses to a set of pathogenic arenaviruses provide broad population coverage. Immunome Res. 6:4.
54. Lamont,A.G., Powell, M.F.,Colon, S.M.,Miles, C., Grey, H.M., and Sette, A. 1990. The use of peptide analogs with improved stability and MHC binding capacity to inhibit antigen presentation in vitro and in vivo. J. Immunol. 144:2493-2498.
55. Lauemoller, S.L., Holm, A., Hilden, J., Brunak, S., Holst Nissen, M., Stryhn, A., Ostergaard Pedersen, L., and Buus, S. 2001. Quantitative predictions of peptide binding to MHC class I molecules using specificity matrices and anchorstratified calibrations. Tissue Antigens 57:405- 414.
56. Lin, H.H., Zhang, G.L., Tongchusak, S., Reinherz, E.L., and Brusic, V. 2008a. Evaluation ofMHCII peptide binding prediction servers: Applications for vaccine research. BMC Bioinformatics 9:S22.
57. Lin, H.H., Ray, S., Tongchusak, S., Reinherz, E.L., and Brusic,V. 2008b. Evaluation ofMHC class I peptide binding prediction servers: Applications for vaccine research. BMC Immunol. 9:8.
58. Ljunggren, H.G., Stam, N.J., Ohlen, C., Neefjes, J.J., Hoglund, P., Heemels, M.T., Bastin, J., Schumacher, T.N.M., Townsend, A., Karre, K., and Ploegh, H.L. 1990. Empty MHC Class I molecules come out in the cold. Nature 346:476- 480.
59. Loffredo, J.T., Sidney, J., Bean, A.T., Beal, D.R., Bardet, W., Wahl, A., Hawkins, O.E., Piaskowski, S., Wilson, N.A., Hildebrand, W.H., Watkins, D.I., and Sette, A. 2009. Two MHC class I molecules associated with elite control of immunodeficiency virus replication, Mamu- B*08 and HLA-B*2705, bind peptides with sequence similarity. J. Immunol. 182:7763-7775.
60. Madden, D.R. 1995. The three-dimensional structure of peptide-MHC complexes. Annu. Rev. Immunol. 13:587-622.
61. Marshall, K.W., Liu, A.F., Canales, J., Perahia, B., Jorgensen, B., Gantzos, R.D., Aguilar, B., Devaux, B., and Rothbard, J.B. 1994. Role of the polymorphic residues in HLA-DR molecules in allele-specific binding of peptide ligands. J. Immunol. 152:4946-4957.
62. McFarland, B.J. and Beeson, C. 2002. Binding interactions between peptides and proteins of the class II Major Histocompatibility Complex. Med. Res. Rev. 22:168-203.
63. Moutaftsi, M., Peters, B., Pasquetto, V., Tscharke, D.C., Sidney, J., Bui, H.H., Grey, H., and Sette, A. 2006. A consensus epitope prediction approach identifies the breadth of murine T(CD8+)-cell responses to vaccinia virus. Nat. Biotechnol. 24:817-819.
64. Nepom B.S., Nepom, G.T., Coleman, M., Kwok, W.W. 1996. Critical contribution of beta chain residue 57 in peptide binding ability of both HLA-DR and -DQ molecules. Proc. Natl. Acad. Sci. U.S.A. 93:7202-7206.
65. Nielsen, M., Justesen, S., Lund, O., Lundegaard, C., and Buus, S. 2010a. NetMHCIIpan-2.0- Improved pan-specific HLA-DR predictions using a novel concurrent alignment and weight optimization training procedure. Immunome Res. 6:9.
66. Nielsen, M., Lund, O., Buus, S., and Lundegaard, C. 2010b. MHC Class II epitope predictive algorithms. Immunology 130:319-328.
67. Olsen, A.C., Pedersen, L.O., Hansen, A.S., Nissen, M.H., Olsen, M., Hansen, P.R., Holm, A., and Buus, S. 1994. A quantitative assay to measure the interaction between immunogenic peptides and purified class I major histocompatibility complex molecules. Eur. J. Immunol. 24:385-392.
68. Oseroff, C., Kos, F., Bui, H.H., Peters, B., Pasquetto, V., Glenn, J., Palmore, T., Sidney, J., Tscharke, D.C., Bennink, J.R., Southwood, S., Grey, H.M., Yewdell, J.W., and Sette, A. 2005. HLA class I-restricted responses to vaccinia recognize a broad array of proteinsmainly involved in virulence and viral gene regulation. Proc. Natl. Acad. Sci. U.S.A. 102:13980-13985.
69. Oseroff, C.,Peters, B., Pasquetto, V., Moutaftsi, M., Sidney, J., Panchanathan, V., Tscharke, D.C., Maillere,B., Grey,H., and Sette,A. 2008. Dissociation between epitope hierarchy and immunoprevalence in CD8 responses to vaccinia virus western reserve. J. Immunol. 180:7193-7202.
70. Oseroff, C., Sidney, J., Kotturi, M.F., Kolla, R., Alam, R., Broide, D.H., Wasserman, S.I., Weiskopf, D., McKinney, D.M., Chung, J.L., Petersen, A., Grey, H., Peters, B., and Sette, A. 2010. Molecular determinants of T cell epitope recognition to the common Timothy grass allergen. J. Immunol. 185:943-955.
71. O'Sullivan, D., Sidney, J., Appella, E., Walker, L., Phillips, L., Colon, S.M., Miles, C., Chesnut, R.W., and Sette, A. 1990. Characterization of the specificity of peptide binding to four DR haplotypes. J. Immunol. 149:1799-1808.
72. O'Sullivan, D., Arrhenius, T., Sidney, J., del Guercio, M-F., Albertson, M., Wall, M., Oseroff, C., Southwood, S., Colon, S.M., Gaeta, F.C.A., and Sette, A. 1991. On the interaction of promiscuous antigenic peptides with different DR alleles: Identification of common structural motifs. J. Immunol. 147:2663-2669.
73. Panina-Bordignon, P., Tan, A., Termijtelen, A., Demotz, S., Corradin, G., and Lanzavecchia, A. 1989. Universally immunogenic T cell epitopes: Promiscuous binding to human MHC class II and promiscuous recognition by T cells. Eur. J. Immunol. 19:2237-2242.
74. Parker, K.C., DiBrino, M., Hull, L., and Coligan, J.E. 1992. The β2-micro-globulin dissociation rate is an accurate measure of the stability of MHC class I heterotrimers and depends on which peptide is found. J. Immunol. 149:1896- 1904.
75. Parker, K.C., Bednarek, M.A., and Coligan, J.E. 1994. Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. J. Immunol. 152:163-175.
76. Pasquetto, V., Bui, H.H., Giannino, R., Banh, C., Mirza, F., Sidney, J.,Oseroff,C., Tscharke,D.C., Irvine, K., Bennink, J.R., Peters, B., Southwood, S., Cerundolo, V., Grey, H., Yewdell, J.W., and Sette, A. 2005. HLA-A*0201, HLAA* 1101, and HLA-B*0702 transgenic mice recognize numerous poxvirus determinants from a wide variety of viral gene products. J. Immunol. 175:5504-5515.
77. Peters, B., Bui, H.-H., Frankild, S., Nielsen, M., Lundegaard, C., Kostem, E., Basch, D., Lamberth, K., Harndahl, M., Fleri, W., Wilson, S.S., Sidney, J., Lund, O., Buus, S., and Sette, A. 2006.Acommunity resource benchmarking predictions of peptide binding to MHC-I molecules. PLoS Comput. Biol. 2:e65.
78. Pinilla, C., Appel, J.R., Blanc, P., and Houghten, R.A. 1992. Rapid identification of high affinity peptide ligands using positional scanning synthetic peptide combinatorial libraries. Biotechniques 13:901-905.
79. Rammensee, H.-G., Friede, T., and Stevanovic, S. 1995. MHC ligands and peptide motifs: First listing. Immunogenetics 41:178-228.
80. Rammensee, H., Bachmann, J., Emmerich, N.P., Bachor, O.A., and Stevanovic, S. 1999. SYFPEITHI: Database for MHC ligands and peptide motifs. Immunogenetics 50:213-219.
81. Reay, P.A.,Wettstein, D.A., and Davis,M.M. 1992. pH dependence and exchange of high and low responder peptides binding to a class II MHC molecule. EMBO J. 11:2829-2839.
82. Rebai, N. and Malissen, B. 1983. Structural and genetic analyses of HLA class I molecules using monoclonal xenoantibodies. Tissue Antigens 22:107-117.
83. Roche, P.A. and Cresswell, P. 1991. High-affinity binding of an influenza hemagglutinin-derived peptide to purified HLA-DR. J. Immunol. 144:1849-1856.
84. Rothbard, J.B. 1994. One size fits all. Curr. Biol. 4:653-655.
85. R̈otzschke, O. and Falk, K. 1994. Origin, structure and motifs of naturally processed MHC class II ligands. Curr. Opin. Immunol. 6:45-51.
86. Ruppert, J., Sidney, J., Celis, E., Kubo, R.T., Grey, H.M., and Sette, A. 1993. Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules. Cell 74:929-937.
87. Schumacher, T.N., Heemels, M.T., Neefjes, J.J., Kast, W.M., Melief, C.J., Ploegh, H.L. 1990. Direct binding of peptide to empty MHC Class I molecules on intact cells and in vitro. Cell 62:563-567.
88. Sette, A. and Grey, H.M. 1992. Chemistry of peptide interactions withMHCproteins. Curr.Opin. Immunol. 4:79-86.
89. Sette, A., Sidney, J., Albertson, M., Miles, C., Colon, S.M., Pedrazzini, T., Lamont, A.G., and Grey, H.M. 1990. A novel approach to the generation of high affinity class II binding peptides J. Immunol. 145:1809-1813.
90. Sette, A., Southwood, S., O'Sullivan, D., Gaeta, F.C.A., Sidney, J., and Grey, H.M. 1992. Effect of pH on MHC class II-peptide interactions. J. Immunol. 148:844-851.
91. Sette, A., Sidney, J., Oseroff, C., del Guercio, M.- F., Southwood, S., Arrhenius, T., Powell, M.F., Colon, S.M., Gaeta, F.C.A., and Grey, H.M. 1993. HLA DR4w4-binding motifs illustrate the biochemical basis of degeneracy and specificity in peptide-DR interactions. J. Immunol. 151:3163-3170.
92. Sette, A., Sidney, J., del Guercio, M-F., Southwood, S., Ruppert, J., Dahlberg, C., Grey, H.M., and Kubo, R.T. 1994. Peptide binding to the most frequent HLA-A class I alleles measured by quantitative molecular binding assays. Mol. Immunol. 31:813-822.
93. Sidney, J., Oseroff, C., Southwood, S., Wall, M., Ishioka, G., Koning, F., and Sette, A. 1992. DRB1*0301 molecules recognize a structural motif distinct from the one recognized by most DRb1 alleles. J. Immunol. 149:2634-2640.
94. Sidney, J., Oseroff, C., del Guercio, M-F., Southwood, S.,Krieger, J.I., Ishioka,G.Y., Sakaguchi, K., Appella, E., and Sette, A. 1994. Definition of a DQ3.1-specific binding motif. J. Immunol. 152:4516-4525.
95. Sidney, J., del Guercio, M.-F., Southwood, S., Engelhard, V.S., Apella, E., Rammensee, H.G., Falk, K., R̈otzschke, O., Takiguchi, M., Kubo, R.T., Grey, H.M., and Sette, A. 1995. Several HLA alleles share overlapping peptide specificities. J. Immunol. 154:247-259.
96. Sidney, J., Grey, H.M., Southwood, S., Celis, E., Wentworth, P.A., del Guercio, M.-F., Kubo, R.T., Chesnut, R.W., and Sette, A. 1996a. Definition of an HLA-A3-like supermotif demonstrates the overlapping peptide binding repertoires of common HLA molecules. Hum. Immunol. 45:79-93.
97. Sidney, J., Southwood, S., del Guercio, M.-F., Grey, H.M., Chesnut, R.W., Kubo, R.T., and Sette, A. 1996b. Specificity and degeneracy in peptide binding to HLA-B7-like class I molecules. J. Immunol. 157:3480-3490.
98. Sidney, J., Southwood, S., Pasquetto, V., and Sette, A. 2003. Simultaneous prediction of binding capacity for multiple molecules of the HLA B44- supertype. J. Immunol. 171:5964-5974.
99. Sidney, J., Peters, B., Moore, C., Pencille, T.J., Ngo, S., Masterman, K.A., Asabe, S., Pinilla, C., Chisari, F.V., and Sette, A. 2007. Characterization of the peptide-binding specificity of the chimpanzee class I alleles A*0301 and A*0401 using a combinatorial peptide library. Immunogenetics 59:745-751.
100. Sidney, J., Assarsson, E., Moore, C., Ngo, S., Pinilla,C., Sette,A., and Peters, B. 2008a.Quantitative peptide binding motifs for 19 human and mouse MHC class I molecules derived using positional scanning combinatorial peptide libraries. Immunome Res. 4:2.
101. Sidney, J., Peters, B., Frahm, N., Brander, C., and Sette, A. 2008b. HLA class I supertypes: A revised and updated classification. BMC Immunol. 9:1.
102. Sidney, J., Steen, A., Moore, C., Ngo, S., Chung, J., Peters, B., and Sette, A. 2010a. Divergent motifs but overlapping binding repertoires of six HLA-DQ molecules frequently expressed in the worldwide human population. J. Immunol. 185:4189-4198.
103. Sidney, J., Steen, A., Moore, C., Ngo, S., Chung, J., Peters, B., and Sette, A. 2010b. Five HLADP molecules frequently expressed in the worldwide human population share a common HLA supertypic binding specificity. J. Immunol. 184:2492-2503.
104. Sinigaglia, F. and Hammer, J. 1994. Defining rules for the peptide-MHC class II interaction. Curr. Opin. Immunol. 6:52-56.
105. Sinigaglia, F., Guttinger, M., Kilgus, J., Doran, D.M., Matile, H., Etlinger, H., Trzeciak, A., Gillessen, D., and Pink, J.R.L. 1988. A malaria T-cell epitope recognized in association with most mouse and humanMHCclass II molecules. Nature 336:778-780.
106. Southwood, S., Sidney, J., Kondo, A., del Guercio, M.-F., Appella, E., Hoffman, S.,Kubo, R.T., Chesnut, R.W., Grey, H.M., and Sette, A. 1998. Several common HLA-DR types share largely overlapping peptide binding repertoires. J. Immunol. 160:3363-3373.
107. Stern, L.J. andWiley, D.C. 1994. Antigenic peptide binding by class I and class II histocompatibility proteins. Structure 2:245-251.
108. Stryhn, A., Pedersen, L.O., Romme, T., Holm, C.B., Holm, A., and Buus, S. 1996. Peptide binding specificity of major histocompatibility complex class I resolved into an array of apparently independent subspecificities: Quantitation by peptide libraries and improved prediction of binding. Eur. J. Immunol. 26:1911-1918.
109. Sylvester-Hvid, C., Kristensen, N., Blicher, T., Ferre, H., Lauemoller, S.L., Wolf, X.A., Lamberth, K., Nissen, M.H., Pedersen, L.O., and Buus, S. 2002. Establishment of a quantitative ELISA capable of determining peptide: MHC class I interaction. Tissue Antigens 59:251-258.
110. Sylvester-Hvid, C., Nielsen, M., Lamberth, K., Roder, G., Justesen, S., Lundegaard, C., Worning, P., Thomadsen, H., Lund, O., Brunak, S., and Buus, S. 2004. SARS CTL vaccine candidates: HLA supertype-, genome-wide scanning and biochemical validation. Tissue Antigens 63:395-400.
111. Townsend, A., Elliott, T., Cerundolo, V., Foster, L., Barber, B., and Tse,A. 1990. Assembly ofMHC class I molecules analyzed in vitro. Cell 62:285- 295.
112. Udaka, K., Wiesmuller, K.H., Kienle, S., Jung, G., and Walden, P. 1995. Decrypting the structure of major histocompatibility complex class I-restricted cytotoxic T lymphocyte epitopes with complex peptide libraries. J. Exp. Med. 181:2097-2108.
113. Udaka, K., Wiesmuller, K.H., Kienle, S., Jung, G., Tamamura, H., Yamagishi, H., Okumura, K., Walden, P., Suto, T., and Kawasaki, T. 2000. An automated prediction of MHC class I-binding peptides based on positional scanning with peptide libraries. Immunogenetics 51:816-828.
114. van Bleek, G.M. and Nathenson, S.G. 1990. Isolation of an endogenously processed immunodominant viral peptide from the class I H-2Kb molecule. Nature 348:213-216.
115. Vita,R., Zarebski, L., Greenbaum, J. A., Emami,H., Hoof, I., Salimi, N., Damle, R., Sette, A., and Peters, B. 2010. The immune epitope database 2.0. Nucleic Acids Res. 38:D854-D862.
116. Wang, P., Sidney, J., Dow, C., Mothe, B., Sette, A., and Peters, B. 2008. A systematic assessment of MHC class II peptide binding predictions and evaluation of a consensus approach. PLoS Comput. Biol. 4:e1000048.
117. Wang, P., Sidney, J., Kim, Y., Sette, A., Lund, O., Nielsen, M., and Peters, B. 2010. Peptide binding predictions for HLA DR, DP and DQ molecules. BMC Bioinformatics 11:568.
118. Wang, P., Sidney, J., Sette, A., and Peters, B. 2011. A computational pipeline to generate MHC binding motifs. Immunome Res. 7:3.
119. Weiskopf, D., Yauch, L.E., Angelo, M.A., John, D.V., Greenbaum, J.A., Sidney, J., Kolla, R.V., De Silva, A.D., de Silva, A.M., Grey, H., Peters, B., Shresta, S., and Sette, A. 2011. Insights into HLA-restricted T cell responses in a novel mouse model of dengue virus infection point toward new implications for vaccine design. J. Immunol. 187:4268-4279.
120. Wulf, M., Hoehn, P., and Trinder, P. 2009. Identification of human MHC class I binding peptides using the iTOPIA-epitope discovery system. Methods Mol. Biol. 524:361-367.